Our May 4th seminar in New York City is now filled. With a topic like “Risk Management as an Anxiolytic: Case Studies in Risk Reduction” it’s no surprise that it has sold out. Due to the limited room capacity, we are unfortunately unable to accommodate everyone. In fact, once registrations began to quickly come in, we worked with the Intrepid to secure a bigger room so that mor ...
April 2014
Special Message: To our clients in areas affected by the recent tornadoes
To our clients in areas affected by the recent tornadoes: We realize that you are dealing with a myriad of issues due to the recent tornadoes. Please know that we are thinking of you as you face these personal and professional concerns. In the coming days, weeks and months you may have questions about the effects on your practice. If you need copies of any pertinent policy info ...
PRMS News Brief: Defense Verdict for Two Psychiatrists
PRMS Panel defense attorneys Laura Herzog of Thomas, Thomas & Hafer (based in Bethlehem, PA) and Tim Holland of The Perry Law Firm (based in Scranton, PA) successfully defended two participants of The Psychiatrists’ Program in a two-week medical malpractice trial. The trial involved allegations of insufficient LFT monitoring for Depakote, and the jury returned a unanimous f ...
Risperdal Litigation: Risk Management Advice for Psychiatrists
If you’ve paid attention to the news lately, you’ve more than likely seen headlines about Johnson & Johnson being involved in litigation related to the marketing of Risperdal. Recently, our clients have begun to receive more requests for medical records in connection with Risperdal litigation. In the event that you receive any such request, we would like to remind you to k ...
CONTACT US TO LEARN MORE!
(800) 245-3333
TheProgram@PRMS.com